Latest Blogs

Guest Commentary
Aug 25, 2023
Ensuring Evidence-Based Medicine Is Reflected in Coding and Reimbursement: An Update From ASCO’s Advisor to the AMA CPT Editorial Panel
Dr. Joseph Merchant introduces the CPT process and recognizes ASCO colleagues who have represented the interests of members on this issue.
Guest Commentary
Aug 23, 2023
What to Expect After Submitting Your Fellowship Application: Tips for Hematology-Oncology Fellowship Application From Current Fellows
HemOncFellows Network organized an online discussion to address the common questions that hematology-oncology fellowship applicants have after submitting their fellowship application.
Guest Commentary
Aug 17, 2023
Advanced Practice Providers (APPs) Are Essential to Continuity of Cancer Care, Especially in Rural Communities
"Oncologists and APPs working together have the opportunity to increase practice volume, improve access to care, and ensure continuity for the patient," said Whitney Pritham.
Nagi S. El Saghir, MD, FASCO, FACP
Aug 09, 2023
Celebrating the 18th Annual Best of ASCO in Beirut
It was such a great pleasure and satisfaction to organize and hold the 18th Annual Best of ASCO (BOA) Lebanon Meeting on July 7-8, 2023, at the American University of Beirut Medical Center.
Subscribe to this column

Matthew S. Katz, MD

Matthew S. Katz, MD, is the medical director of radiation oncology at Lowell General Hospital and a partner in Radiation Oncology Associates, PA. He is former chair of the Communications Committee for the American Society for Radiation Oncology (ASTRO) and External Advisory Board member for Mayo Clinic Center for social media. He has served on ASCO's Social Media Working Group, ASTRO's Education Committee, and Massachusetts Medical Society's Communications Committee. His areas of primary interest are patient education and health empowerment. Follow Dr. Katz on Twitter @subatomicdoc.

Disclosure.

Mar 23, 2020
Cancer Care in the Time of COVID-19
We can work to limit the spread of COVID-19 while providing humane, evidence-based cancer care.
2 Comments
Feb 19, 2020
For Whom the Cancer Bell Tolls — Or Should It?
Let’s look critically at the prospective trial evaluating the association of ringing a bell with distress experienced by patients with cancer.
Nov 15, 2018
Bringing Patients and Pathologists Together
During my career, pathologists have always been the “doctor’s doctor.” Why can't they be the "patient's doctor" as well?
3 Comments
Dec 06, 2017
True Impact: How to Align Health Care Improvement, Academic Advancement Through Better Communication
Only 11% of randomized trials give enough detail to practically use in clinical practice. Here are five ways we can use internet-based communication to make it easier for academic innovators to get credit for their work, and  to implement new findings for our patients.
Jul 12, 2017
Postoperative Radiotherapy for Malignant Melanoma: 10 Reasons to Renew Research in the Age of Immunotherapy
Here are 10 reasons why we should look at postoperative radiation for regional melanoma.
2 Comments
Jul 19, 2016
Stakeholders Before Shareholders: Seven Ways to Make Big Pharma a Better Citizen
Drug companies play a key role in improving cancer care, but financial toxicity for patients continues to worsen. Eternal vigilance is the price of liberty from excessive drug costs, and we have an ethical obligation to hold pharmaceutical companies accountable.
1 Comments

Pages